Agenus (AGEN)

3.59 -0.10 (2.71%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/4/20 *Est.)

Latest Headlines

Agenus R&D Update & Third Quarter Financial Report October 29, 2020 7:46 AM - StreetInsider Form 8-K AGENUS INC For: Oct 29 October 29, 2020 7:45 AM - SEC Filing Agenus R&D Update & Third Quarter Financial Report October 29, 2020 7:45 AM - Globe NewsWire Form 4 AGENUS INC For: Oct 23 Filed by: ARMEN GARO H October 23, 2020 8:51 PM - SEC Filing Agenus to Report Third Quarter Earnings October 20, 2020 10:35 AM - StreetInsider Agenus to Report Third Quarter Earnings October 20, 2020 10:34 AM - Globe NewsWire Agenus to Present on Seven Novel Programs at SITC 2020 October 14, 2020 5:01 PM - StreetInsider Agenus to Present on Seven Novel Programs at SITC 2020 October 14, 2020 5:00 PM - Globe NewsWire Form 4 AGENUS INC For: Oct 08 Filed by: Hirsch Susan B October 13, 2020 10:20 AM - SEC Filing Form 3 AGENUS INC For: Oct 08 Filed by: Hirsch Susan B October 13, 2020 10:02 AM - SEC Filing Form 8-K AGENUS INC For: Oct 08 October 13, 2020 8:55 AM - SEC Filing Susan Hirsch Joins Agenus’ Board of Directors October 13, 2020 8:31 AM - StreetInsider Susan Hirsch Joins Agenus’ Board of Directors October 13, 2020 8:30 AM - Globe NewsWire Form 4 AGENUS INC For: Oct 09 Filed by: ARMEN GARO H October 9, 2020 4:50 PM - SEC Filing Form 4 AGENUS INC For: Oct 01 Filed by: WIINBERG ULF October 1, 2020 3:00 PM - SEC Filing Form 4 AGENUS INC For: Oct 01 Filed by: JORDAN WADIH October 1, 2020 2:48 PM - SEC Filing Form 4 AGENUS INC For: Oct 01 Filed by: Wright Timothy October 1, 2020 2:29 PM - SEC Filing Form 4 AGENUS INC For: Sep 25 Filed by: ARMEN GARO H September 25, 2020 4:35 PM - SEC Filing Agenus Inc. (AGEN) PT Raised to $8 at Jefferies September 18, 2020 11:42 AM - StreetInsider Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer September 18, 2020 8:31 AM - StreetInsider Agenus (AGEN) Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer September 18, 2020 8:29 AM - StreetInsider Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer September 18, 2020 8:29 AM - Globe NewsWire Agenus (AGEN) Presents Results from Two Large Cervical Cancer Trials at ESMO September 18, 2020 6:08 AM - StreetInsider Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO September 18, 2020 3:01 AM - StreetInsider Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO September 18, 2020 3:00 AM - Globe NewsWire Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With September 17, 2020 5:07 PM - StreetInsider Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With September 17, 2020 5:05 PM - Globe NewsWire Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline September 17, 2020 1:39 PM - StreetInsider Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline September 17, 2020 1:38 PM - Globe NewsWire Form 4 AGENUS INC For: Sep 11 Filed by: ARMEN GARO H September 11, 2020 9:22 PM - SEC Filing Increasing unusual option volume: AGEN LAUR September 11, 2020 9:41 AM - StreetInsider Form 4 AGENUS INC For: Aug 27 Filed by: CLARK PAUL N August 31, 2020 9:59 AM - SEC Filing Form 3 AGENUS INC For: Aug 27 Filed by: CLARK PAUL N August 31, 2020 9:55 AM - SEC Filing Form 8-K AGENUS INC For: Aug 27 August 31, 2020 8:24 AM - SEC Filing Paul Clark Joins Agenus Board of Directors August 31, 2020 8:00 AM - PR NewsWire Form 4 AGENUS INC For: Aug 28 Filed by: ARMEN GARO H August 28, 2020 4:34 PM - SEC Filing Companies with NDRs 08/27 August 27, 2020 7:58 AM - StreetInsider Agenus (AGEN) Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer August 26, 2020 2:48 PM - StreetInsider Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer August 26, 2020 2:46 PM - PR NewsWire Companies with NDRs 08/26 August 26, 2020 8:34 AM - StreetInsider Companies with NDRs 08/25 August 25, 2020 7:17 AM - StreetInsider Companies with NDRs 08/24 August 24, 2020 8:33 AM - StreetInsider Form 4 AGENUS INC For: Aug 14 Filed by: ARMEN GARO H August 14, 2020 4:55 PM - SEC Filing Form 10-Q AGENUS INC For: Jun 30 August 10, 2020 3:04 PM - SEC Filing Form 8-K AGENUS INC For: Aug 06 August 10, 2020 12:48 PM - SEC Filing Agenus (AGEN) Misses Q2 EPS by 1c August 6, 2020 8:16 AM - StreetInsider Agenus Provides R&D Update & Second Quarter Financial Report August 6, 2020 7:30 AM - PR NewsWire Agenus to Present on Targeting Myeloid Cells in Tumor Microenvironment at the William Blair Biotech Focus 2020 Conference August 4, 2020 8:30 AM - PR NewsWire Form 4 AGENUS INC For: Jul 31 Filed by: ARMEN GARO H July 31, 2020 5:16 PM - SEC Filing Form SC 13G AGENUS INC Filed by: FEINBERG LARRY N July 31, 2020 6:04 AM - SEC Filing Full Article List